1910

1910 is an AI-native biotech company that has developed the ITO™ platform, a multimodal and modality-agnostic AI infrastructure specifically designed for the pharmaceutical industry. This platform integrates various types of data, including wet lab, computational, and proxy data, to aid companies in the drug discovery process, particularly in addressing the challenges associated with previously undruggable targets. By leveraging advanced AI models and high-throughput laboratory automation, 1910 aims to enhance the efficiency and effectiveness of drug development, significantly reducing the tim…